About

Provided by Cravath, Swaine & Moore LLP

Cravath represents some of the largest and most highly regarded companies in the healthcare and life sciences industries, providing counsel on a variety of corporate and litigation matters across the entire global innovation marketplace. We have played a leading role in critical and complex matters that have defined these industries, creating long‑standing client relationships and enhancing our ability to handle the unique matters in these sectors.

Our corporate lawyers have steered some of the largest and most significant U.S. and non‑U.S. transactions in the healthcare and life sciences industries. We have advised a full spectrum of companies, from biotechnology startups to established healthcare and life sciences companies, in connection with transactions ranging from complex collaboration agreements to a wide variety of acquisitions and divestitures of companies and businesses.

Our litigators have an extensive understanding of substantive issues coupled with deep trial experience in the healthcare and life sciences areas. We have handled matters for pharmaceutical, healthcare services and medical device companies, including antitrust litigation and regulatory clearance, class actions, shareholder derivative and securities suits, breach of contract and licensing disputes and arbitrations. Our experience also extends to the field of biotechnology, with particular expertise navigating the biologics and biosimilars landscape.

Chambers Review

Provided by Chambers

Life Sciences - USA - Nationwide

5
Band 5

What the Team is Known For

Cravath, Swaine & Moore LLP is noted for its extensive life sciences litigation practice. The team has broad and deep experience representing clients at trial and appellate level in cases concerning patent infringement, antitrust violations, reverse-payment disputes and False Claims Act issues. The team also has experience advising household-name clients on the intellectual property aspects of mergers and acquisitions.

Notable practitioners

Keith Hummel is a key contact.

Work Highlights

  • Cravath, Swaine & Moore LLP continued to represent Kenvue Inc., in connection with its $48.7 billion acquisition by Kimberly-Clark Corporation.